NAD+ and Longevity: The Complete 2026 Deep Dive on Cellular Energy, Mitochondrial Health, and Aging Well

Walk into any longevity conference, biohacking podcast, or wellness clinic in 2026 and one molecule keeps coming up: NAD+. Researchers describe it as the most studied coenzyme of the last decade. Clinicians treat it as a tool for energy, recovery, and cellular health. Patients ask whether it can actually slow aging. And underneath the marketing, there is a remarkable amount of legitimate biochemistry to unpack.

This guide is the long version. We are going to walk through what NAD+ actually is, why it declines with age, how it interacts with sirtuins and DNA repair and mitochondria, what the literature genuinely supports, what is still aspirational, and how a thoughtful clinical protocol fits into a broader healthspan strategy. We will be honest about the evidence levels. We will not pretend NAD+ is a fountain of youth. But we will explain why, when used inside a careful, supervised plan, it has earned its place in the longevity conversation.

If you are new to NAD+, this article will give you the full picture. If you are already familiar with the basics from the Impact Health blog or our NAD+ services overview, this is the deeper dive — biochemistry, hallmarks of aging, delivery methods compared, stacking strategies, and the honest research summary in one place.

What NAD+ Actually Is — and Why "Longevity" People Will Not Stop Talking About It

NAD+ stands for nicotinamide adenine dinucleotide. The "+" denotes its oxidized state. It is a coenzyme — meaning it partners with enzymes to make biochemical reactions happen — and it is found in every living cell on Earth, from yeast to oak trees to the cells in your liver. It is not a vitamin, although it is built from vitamin B3 precursors. It is not a hormone. It is not a drug. It is one of the most fundamental molecules in metabolism.

The reason longevity researchers care about NAD+ is that it sits at the intersection of three of the most important biological processes that decline with age: energy production, DNA repair, and gene regulation. When NAD+ is abundant, your cells make ATP efficiently, your DNA-repair enzymes have the substrate they need, and your sirtuins — a family of longevity-associated regulatory proteins — can keep your epigenome organized. When NAD+ is depleted, all three of those processes suffer simultaneously.

NAD+ levels decline with age. Multiple human studies show roughly a 50 percent reduction in tissue NAD+ between early adulthood and the seventh decade of life. The decline is not linear and not identical in every tissue, but the trend is real, reproducible, and consistent across species. Researchers studying everything from muscle biopsies to skin fibroblasts to brain tissue have documented the same pattern: less NAD+ as we age.

That single observation has driven an enormous amount of research. If we know NAD+ declines, and we know what NAD+ does, and we can replenish it through precursors or direct administration, then we have a plausible mechanistic lever to pull on the biology of aging itself. Whether that lever extends human lifespan is still an open question. Whether it improves how people feel and function during the years they have — that is a question with a much clearer answer.

The Biochemistry Primer

To understand why NAD+ matters, you need a working mental model of what it does inside a cell. We will keep it accessible but accurate.

NAD+ and NADH: The Redox Currency

NAD+ shuttles electrons. That is its day job. It exists in two interconvertible forms:

• NAD+ (oxidized): Empty. Ready to accept electrons.
• NADH (reduced): Loaded. Carrying electrons it picked up from food molecules.

When you eat a meal, your cells break down glucose, fatty acids, and amino acids. The electrons released by those reactions are caught by NAD+, converting it to NADH. NADH then carries those electrons to the inner mitochondrial membrane, where they are used to power the production of ATP — the actual energy currency of the cell. Once NADH delivers its electrons, it converts back to NAD+, ready to do it again.

This cycle happens billions of times per second in every cell. It is the reason you can move, think, beat your heart, regulate your body temperature, and read this sentence. Without an adequate NAD+/NADH pool, none of it works.

NAD+ and NADP+: A Related Cousin

NAD+ has a phosphorylated relative called NADP+. Both molecules carry electrons, but they have different jobs. NAD+ is mostly involved in catabolism — breaking things down to extract energy. NADP+ (and its reduced form NADPH) is mostly involved in anabolism — building things, particularly fatty acids and nucleotides — and in maintaining cellular antioxidant systems through glutathione regeneration. The body interconverts NAD+ and NADP+ as needed. Healthy NAD+ pools generally support healthy NADP+ pools.

The Electron Transport Chain

The electron transport chain (ETC) is a series of protein complexes embedded in the inner mitochondrial membrane. NADH delivers its electrons to Complex I. Those electrons cascade through the chain, and as they move, they pump protons across the membrane. The resulting proton gradient powers ATP synthase — a remarkable molecular turbine that physically rotates as protons flow through it, generating ATP in the process.

This is where the bulk of cellular energy is produced. It is also where things go wrong as we age. Mitochondrial dysfunction — meaning a less-efficient electron transport chain, more electron leakage, more reactive oxygen species — is one of the recognized hallmarks of aging. NAD+ availability is upstream of all of it.

Sirtuins: The Longevity Regulators

Sirtuins are a family of seven proteins in humans, named SIRT1 through SIRT7. They are deacetylases — enzymes that remove acetyl groups from other proteins, including histones, the proteins that DNA wraps around. By doing so, they regulate which genes are expressed and how the genome is organized.

The catch: every deacetylation reaction a sirtuin performs consumes one molecule of NAD+. Sirtuins do not just need NAD+; they spend it. When NAD+ is plentiful, sirtuins work. When NAD+ falls, sirtuins idle. This is why low NAD+ is associated with the kind of dysregulated gene expression seen in aged tissues.

Different sirtuins live in different cellular compartments. SIRT1, SIRT6, and SIRT7 are mostly nuclear and regulate gene expression and DNA repair. SIRT3, SIRT4, and SIRT5 are mitochondrial and regulate energy metabolism. SIRT2 floats between the cytoplasm and nucleus. We will return to them.

PARP Enzymes: The DNA Damage Responders

PARPs — poly(ADP-ribose) polymerases — are enzymes that detect DNA damage and recruit repair machinery. They use NAD+ as their fuel. A single severe DNA-damage event can activate PARP1 enough to consume an enormous fraction of cellular NAD+ in minutes.

When you are young and healthy, this is fine. PARPs do their job, NAD+ gets replenished, life continues. When you are older, or chronically inflamed, or exposed to ongoing oxidative stress, PARP activity is high all the time, and the cellular NAD+ pool is constantly being drained. This is one of the proposed mechanisms behind the age-related decline in NAD+.

CD38: The NAD+ Glutton

CD38 is an enzyme on the surface of immune cells that — among other functions — degrades NAD+. CD38 expression rises with age, partly because chronic low-grade inflammation drives it. Higher CD38 means faster NAD+ degradation, which means lower steady-state NAD+ levels even if production is unchanged. CD38 has become a target of interest in longevity research precisely because suppressing it might preserve NAD+ pools without supplementation.

So we have three NAD+ consumers — sirtuins, PARPs, and CD38 — all of which trend in directions that drain NAD+ as we age. We have a synthesis pathway that gets less efficient with age. The result is the age-related NAD+ decline that has become a central observation of the longevity field.

How the Body Synthesizes NAD+

Cells make NAD+ through three main routes. Understanding them clarifies why oral precursors work and why some are better than others.

• The de novo pathway: Builds NAD+ from the amino acid tryptophan. Slow, expensive, and a small contributor to most tissues. Important biologically but not the workhorse.
• The Preiss-Handler pathway: Uses nicotinic acid (niacin) as a starting material. Active in many tissues, especially the liver.
• The salvage pathway: By far the dominant route in most cells. Recycles nicotinamide — the breakdown product of NAD+-consuming reactions — back into NAD+. The salvage pathway is what NMN and NR slot into directly.

The salvage pathway is regulated by an enzyme called NAMPT (nicotinamide phosphoribosyltransferase). NAMPT activity declines with age in many tissues, which is part of why endogenous NAD+ production gets less efficient over the decades. Anything that supports NAMPT — including, indirectly, exercise and caloric stress — supports NAD+ regeneration. This is one of the reasons exercise is so durable as a longevity intervention.

The Aging-NAD+ Connection

The NAD+-decline-with-age finding is one of the most consistently reproduced observations in longevity biology. Studies in mice, rats, monkeys, and humans all show the same general pattern: tissue NAD+ levels are highest in young adulthood and fall progressively over the decades.

What does the decline curve look like in humans? Approximations from peer-reviewed work suggest:

• Ages 20 to 40: Relatively stable, with slow gradual decline.
• Ages 40 to 60: Steeper drop, with some studies showing 30 to 50 percent reductions in skin and muscle NAD+.
• Ages 60 to 80: Continued decline, often to 20 to 30 percent of young-adult levels in some tissues.

The pattern is tissue-specific. Skin NAD+ falls earlier than brain NAD+ in some studies. Skeletal muscle NAD+ correlates with mitochondrial function. Liver NAD+ is influenced heavily by metabolic health and alcohol exposure. The decline is general, but the pace varies.

The clinical correlations are what make this interesting. Lower NAD+ is associated with reduced exercise capacity, slower recovery, more fatigue, more cognitive complaints, and worse markers of metabolic health. Whether NAD+ decline causes these things or whether it is downstream of the same underlying aging biology is still being unpacked. Most likely it is both — NAD+ decline is partly cause and partly consequence, sitting at a node in a network rather than at the top of a hierarchy.

That is the honest framing. NAD+ is not the only thing that changes with age. It is one of many. But it is one of the more tractable ones, because we have ways to influence it.

Why the Decline Happens

Why exactly does NAD+ fall with age? The answer is that several things change at once. Synthesis slows because NAMPT activity drops in some tissues. Consumption rises because chronic low-grade inflammation drives PARP and CD38 activity. The body becomes less efficient at recycling nicotinamide back into NAD+, and senescent cells — the so-called "zombie cells" that accumulate with age — secrete signals that further increase NAD+ consumption in surrounding tissue.

In other words, the NAD+ deficit of aging is a manufacturing problem, a consumption problem, and a recycling problem rolled together. There is not a single bottleneck to fix. This is part of why combining NAD+ replenishment with anti-inflammatory and metabolically supportive lifestyle work produces better outcomes than any single intervention can on its own.

Why It Matters Symptomatically

The reason patients walk through our door asking about NAD+ usually starts with how they feel. The symptom cluster that often accompanies low NAD+ — fatigue that does not fully resolve with sleep, slower recovery from exercise, decreased mental endurance, more variable mood, sluggish digestion, less restorative sleep — is the kind of slow, drifting decline that does not show up sharply on a standard physical but gradually robs people of energy and engagement. Replenishing NAD+, when other contributors are addressed in parallel, often returns at least some of that.

Sirtuins and SIRT1-7: What They Regulate

If NAD+ is the substrate, sirtuins are the most-studied class of enzymes that depend on it for longevity-relevant work. A quick tour of the family:

SIRT1

The most-studied sirtuin. Located mainly in the nucleus. Regulates a vast number of metabolic and stress-response genes. Activated by caloric restriction. Influences insulin sensitivity, fatty acid oxidation, and circadian rhythms. Plays a role in the body's response to exercise and fasting.

SIRT2

Found in the cytoplasm and nucleus. Involved in cell cycle regulation and microtubule stability. Implicated in the response to oxidative stress.

SIRT3

The major mitochondrial sirtuin. Regulates the activity of many mitochondrial enzymes, including those in the citric acid cycle and the electron transport chain. Critical for fatty acid oxidation and mitochondrial antioxidant defense (it activates manganese superoxide dismutase). Loss of SIRT3 function is associated with accelerated mitochondrial aging.

SIRT4

Mitochondrial. Regulates amino acid metabolism and insulin secretion. Less studied than its siblings but emerging as relevant.

SIRT5

Mitochondrial. Catalyzes more unusual chemical reactions (desuccinylation, demalonylation). Regulates the urea cycle and ketone body production.

SIRT6

Nuclear. Critical for genomic stability and DNA repair. Regulates telomere maintenance. Mice with extra SIRT6 live measurably longer; mice without it age dramatically faster. One of the strongest single-gene longevity links discovered.

SIRT7

Located in the nucleolus, where ribosomes are made. Regulates ribosomal RNA transcription and the response to cellular stress. Involved in maintaining the silenced state of certain regions of the genome.

The unifying theme: sirtuins are gatekeepers of cellular stress response, metabolic flexibility, and genomic integrity. Their activity depends on NAD+. When NAD+ falls, the entire sirtuin orchestra plays softer. When NAD+ is replenished, the music can come back — though it depends on how the rest of the cell is doing.

PARP and DNA Repair: The Inflammation-and-Damage Drain

Every day, every cell in your body experiences an estimated tens of thousands of DNA damage events. Most are minor and repaired quickly. Some are severe — double-strand breaks, oxidative base damage, replication errors. The cell has multiple repair pathways, and PARP enzymes are central to several of them.

When PARP1 detects damage, it binds to the damaged DNA and starts adding chains of ADP-ribose units to nearby proteins, including itself. Those chains serve as a beacon, recruiting the rest of the repair machinery. Each ADP-ribose unit comes from one molecule of NAD+. The reaction is fast, costly, and effective.

The problem comes when the damage signal is chronic. Chronic inflammation generates reactive oxygen and nitrogen species. Those species damage DNA continually. PARPs are activated continually. NAD+ is consumed continually. And when NAD+ runs low, sirtuins can no longer compete for the same substrate pool — they essentially get starved out by the more aggressive PARPs.

This is why anti-inflammatory living matters so much for longevity. Not because inflammation is "bad" in the abstract, but because chronic inflammation drains the very molecule your cells need to maintain themselves. Sleep, exercise, nutrition, stress management, and reasonable alcohol use all reduce the inflammatory load and therefore preserve NAD+.

CD38: The NAD+-Consuming Enzyme That Climbs With Inflammation

CD38 deserves its own section because it is one of the more interesting recent discoveries in NAD+ biology. It is an ectoenzyme, meaning it lives on the cell surface, and one of its activities is to break down NAD+ and related metabolites. CD38 expression rises with age and rises with inflammation.

What this means in practice: even if you supplement NAD+ precursors generously, if your CD38 is high, a meaningful fraction of the NAD+ you produce gets degraded before it can be used. This is one reason why some patients with chronic inflammatory conditions report needing higher doses or more frequent administration to feel a difference.

This also reinforces a point that runs through this whole article: NAD+ does not exist in isolation. The same lifestyle and biochemical factors that drive aging also drive CD38 expression. Treating only the NAD+ side of the equation while ignoring the inflammatory side leaves a lot on the table.

NAD+ Delivery Methods Compared

Once you accept that NAD+ matters and declines with age, the next question is: how do you replenish it? There are several clinical and over-the-counter options. Each has different evidence, different pharmacokinetics, and different practical trade-offs.

IV NAD+

Intravenous NAD+ delivers the molecule directly into the bloodstream, bypassing the gut entirely. This is the highest-dose, most-studied clinical delivery method outside of formal pharmaceutical trials. Sessions typically run two to four hours because the infusion has to be administered slowly — pushing NAD+ in too fast causes a flushing, pressure-in-the-chest sensation that resolves with slowing the drip.

What the evidence supports for IV NAD+:

• Robust, repeatable patient-reported improvements in energy and mental clarity
• Faster recovery from physical exertion in active patients
• Improved focus and cognitive endurance in many recipients
• Adjunctive value in addiction recovery protocols
• Anecdotal but consistent reports of improved sleep quality

What the evidence does not yet support:

• A specific lifespan-extension claim in humans
• Cure or reversal of any specific age-related disease
• Permanent change after a single session

IV NAD+ is best thought of as a tool for replenishing cellular NAD+ in patients who feel and function noticeably better when they do it. It is not a guarantee of longer life. It is a credible way to improve how the years feel.

Learn more about our IV NAD+ approach on the NAD+ services page, or check availability at Oxford, Olive Branch, or Corinth.

IM (Intramuscular) Injections

NAD+ injections are smaller, faster, and more practical than IV infusions. A typical injection takes seconds. Patients can do them at home after an in-clinic onboarding. They are useful for maintenance after a loading IV course, or for patients who cannot dedicate the time for IV infusions but still want consistent NAD+ support.

The bioavailability is lower than IV (intramuscular injection has to pass through tissue and reach circulation), but with regular dosing the steady-state effect is meaningful. Many patients run a hybrid protocol: a short IV loading phase, then weekly or biweekly IM injections to maintain.

Sublingual and Nasal NAD+

Sublingual troches and nasal sprays are convenient delivery routes that bypass first-pass liver metabolism. The pharmacokinetics are not as well characterized as IV or IM, and the delivered doses are smaller, but for some patients these provide a useful daily top-up. They tend to be best used as an adjunct to a primary IV or IM protocol rather than as the sole intervention.

Oral Precursors: NMN, NR, Niacin, Niacinamide

This category is where most over-the-counter "NAD+ boosters" live. None of these products contain NAD+ itself in a form that survives oral administration. Instead, they contain precursors that the body uses to synthesize NAD+ through one of three salvage or de novo pathways.

Nicotinamide riboside (NR): A direct NAD+ precursor that has been studied in multiple human trials. It reliably raises blood NAD+ markers. The clinical effects on energy, biomarkers, and function are real but generally modest.

Nicotinamide mononucleotide (NMN): One step closer to NAD+ in the salvage pathway than NR. Studied extensively in animal models with promising results. Human trials are accumulating and generally show favorable effects on biomarkers, with the strongest effects in specific populations (older adults, prediabetic individuals, postmenopausal women in some studies).

Niacin (nicotinic acid): The original B3. Effective at raising NAD+ but causes flushing at higher doses and has a long history of use for cardiovascular indications. Useful, but not the most comfortable precursor.

Niacinamide (nicotinamide): A non-flushing form of B3 that supports NAD+ synthesis. Found in many multivitamins. Also a substrate the body cycles back into NAD+. At very high doses, niacinamide can actually inhibit sirtuins, which is something to be aware of.

The honest summary on oral precursors: they work in the sense that they raise blood NAD+. The clinical effects are real but generally less dramatic than what patients report from IV or IM administration. For everyday maintenance and as part of a broader healthspan strategy, they are reasonable. For symptomatic energy or recovery issues, they are usually not enough on their own.

For a comparison of how these delivery routes fit into our overall approach, see our NAD+ services overview.

The Protocol Design Question

"How much, how often" is the question every NAD+ patient asks. The honest answer is that protocols are individualized — and that any clinic giving you a one-size-fits-all dose without first looking at your labs and your goals is doing it wrong.

That said, the broad shape of a thoughtful protocol looks something like this:

The Loading Phase

For patients with significant fatigue, post-illness recovery needs, or measurable signs of mitochondrial dysfunction, a loading phase is often worthwhile. This typically means a series of IV sessions concentrated over a few weeks. The goal is to saturate cellular NAD+ pools and get the patient to a state where maintenance is meaningful. Many patients describe a noticeable shift in energy, sleep, and clarity during or after a loading phase.

The Maintenance Phase

After loading, most patients move to a less frequent maintenance schedule — IV sessions monthly or quarterly, or weekly to biweekly IM injections, often combined with oral precursors. The goal is to keep cellular NAD+ supported without the time and cost of a perpetual IV schedule.

The Preventive Phase

For healthy patients who are not symptomatic but want to support healthy aging, lower-frequency NAD+ work — quarterly IVs, daily oral precursors, periodic IM injections — fits naturally into a broader prevention-focused plan. This is where NAD+ becomes one tool among many, integrated with lifestyle, lab monitoring, body composition tracking, and other targeted therapies.

We deliberately avoid quoting specific milligram doses in this article because dosing should come from a real evaluation, not from a blog post. What matters more than the exact number is the pattern: load when it makes sense, maintain when it makes sense, and let the data — labs, symptoms, body composition, recovery metrics — guide adjustments over time.

Stacking NAD+ With Peptides for Synergistic Effects

One of the more interesting developments in longevity-oriented practice is the combination of NAD+ with selected peptide therapies. The reasoning is biological: NAD+ supports the substrate side of cellular work, and peptides provide signaling that activates specific repair, growth, or regulatory pathways. Done carefully, the combination is often more useful than either alone.

Epitalon

A short peptide originally developed in research focused on telomere biology and circadian regulation. In the longevity-focused practice, epitalon is sometimes used in cycles to support sleep architecture and circadian regularity. It pairs well with NAD+ because both touch the same general territory — cellular maintenance and rhythm — through different mechanisms.

Sermorelin

A growth hormone-releasing hormone analog that prompts the pituitary to release endogenous growth hormone in physiologic pulses. Sermorelin is used to support sleep quality, body composition, and recovery. The interaction with NAD+ is indirect but meaningful — better growth hormone signaling supports tissue repair and metabolism, both of which depend on adequate NAD+ pools.

BPC-157

A peptide studied for tissue repair, particularly in connective tissue and gut lining. Not a longevity peptide per se, but extremely useful in patients recovering from injury or chronic gut issues. NAD+ supports the energy demands of tissue repair; BPC-157 supports the signaling. The combination is one of the more popular stacks in active patients.

These are not magic. None of them have been shown to extend human lifespan. They are tools for supporting specific physiologic processes that tend to falter with age. When combined thoughtfully with NAD+ in a supervised setting, they can produce noticeable improvements in how patients feel and function.

For more on peptide options, see our peptide therapy page.

The Metabolic and Mitochondrial Connection

NAD+ is metabolic real estate. Every metabolic process you care about — burning fat, generating ATP, producing or clearing reactive oxygen species, regulating blood sugar — runs through NAD+ to some degree. This is why metabolic health and NAD+ status are inseparable.

Mitochondrial Biogenesis

Mitochondrial biogenesis is the process of making new mitochondria. It is regulated by a master switch called PGC-1-alpha, which itself is regulated by SIRT1 (which depends on NAD+) and AMPK (the cellular energy-sensor). When NAD+ is plentiful and energy demand is high, the cell is signaled to build more mitochondria. When NAD+ is depleted and inflammation is dominant, the opposite happens.

This is the molecular link between exercise and longevity: exercise activates AMPK, raises NAD+ turnover, activates SIRT1 and SIRT3, and stimulates the building of new mitochondria. Patients who exercise consistently are essentially running their own NAD+ and mitochondrial maintenance program every time they train.

Caloric Restriction and Fasting

Caloric restriction is the most reproducible lifespan-extending intervention in animal research. It works through many mechanisms, but one of the most prominent is the activation of SIRT1 and other sirtuins, partly via shifts in the NAD+/NADH ratio toward NAD+. Time-restricted eating and intermittent fasting do something similar on a smaller scale — they push the cell into a state where NAD+ is more abundant relative to NADH, and sirtuin-driven maintenance gets a green light.

You do not need to crash-diet to benefit from this. Reasonable eating windows, avoiding constant grazing, and not eating immediately before bed all push your physiology toward better NAD+ utilization.

Sleep

Sleep is when many of the body's repair processes — including those that depend on NAD+ — run at peak efficiency. Sleep deprivation lowers NAD+ availability and shifts metabolism in unfavorable directions. There is no NAD+ protocol that compensates for chronic poor sleep.

Exercise

Both endurance training and resistance training improve mitochondrial function and NAD+ handling. The two modalities work through somewhat different mechanisms and complement each other. Sedentary patients can sometimes get partial benefits from NAD+ work even without exercise, but the patients who get the most out of it are almost always those who move regularly.

This is why we like to combine NAD+ work with body composition analysis: it lets us see how training and metabolic interventions are translating into measurable changes in lean mass and fat distribution over time.

The Hallmarks of Aging — and Where NAD+ Touches Each One

In 2013, a paper by Lopez-Otin and colleagues organized aging biology into a framework called the hallmarks of aging. The framework was updated in 2023. The hallmarks are a useful way to think about what NAD+ actually does, because the molecule touches a striking number of them.

The hallmarks include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis.

Where does NAD+ show up?

• Genomic instability: NAD+ fuels PARPs and supports DNA repair.
• Epigenetic alterations: NAD+ fuels sirtuins, which regulate the epigenome.
• Mitochondrial dysfunction: NAD+ is essential for the electron transport chain and for SIRT3 in mitochondria.
• Deregulated nutrient sensing: NAD+ feeds into AMPK, SIRT1, and the broader sensing network.
• Cellular senescence: NAD+-dependent pathways influence whether cells become senescent and how they signal once they do.
• Chronic inflammation: CD38 (which consumes NAD+) is driven by inflammation, creating a feedback loop.

NAD+ does not "treat" aging. There is no single intervention that does. But it is one of the molecules with the broadest reach across the hallmarks framework, and that is part of why it has captured so much attention.

The Network View

One reason longevity researchers prefer to talk in terms of hallmarks rather than single mechanisms is that aging is a network phenomenon. Pull on one thread and the others move. Improve mitochondrial function and you reduce the oxidative stress that drives DNA damage that activates PARPs that drain NAD+ that limits sirtuin activity that, in turn, regulates mitochondrial biogenesis. The loops are real, and that is exactly what makes interventions like NAD+ replenishment plausible — touching one node ripples through several others.

It is also what makes longevity work humbling. There is no clean experimental arm where you change one variable and watch lifespan tick up. Real-world healthspan comes from improving the network as a whole — sleep, training, nutrition, stress, hormones, NAD+, peptides, body composition — and watching the patient's trajectory over years.

The Honest Research Summary: What the Literature Actually Shows

This is the section where we try to keep the marketing voice off the page. Here is what the published literature genuinely supports as of 2026, what is promising but not yet conclusive, and what is over-claimed.

What the Evidence Supports

• NAD+ declines with age. Reproduced across species and tissues. Solid.
• Raising NAD+ improves cellular markers of energy metabolism. Demonstrated in human trials with NR and NMN.
• NAD+ supports DNA repair and sirtuin activity. Foundational biochemistry, not in dispute.
• Patients with fatigue, post-viral syndromes, and recovery needs frequently report meaningful symptomatic improvement. Clinical evidence and patient-reported outcomes consistent across many practices.
• NAD+ precursors are generally well tolerated. Safety data in humans is reassuring at studied doses.

What Is Promising but Not Conclusive

• Cognitive performance improvements. Many patients report it. Some studies suggest it. The data is not yet at the level of a definitive claim.
• Metabolic and cardiovascular benefits. Animal data is strong; human data is encouraging but limited.
• Long COVID and post-viral syndrome support. Clinical reports are consistent and biologically plausible. Formal evidence is still being built.
• Synergy with peptides and hormone optimization. Mechanistically reasonable; clinically observed; not yet rigorously studied.

What Is Over-Claimed

• Lifespan extension in humans. Has not been demonstrated. Animal lifespan extension in some studies does not automatically translate.
• Disease cures. NAD+ is not a treatment for any specific disease. Anyone selling it as such is overstating things.
• Reversal of aging. Aging is not reversed by any current intervention. NAD+ supports the biology of aging well; it does not turn back the clock.
• Permanent change from one IV. Cellular NAD+ pools turn over. Sustained benefit requires sustained support, not a one-time event.

This is the framing we want patients to walk in with: realistic, biology-grounded expectations. NAD+ is a useful tool. It is not a miracle. The patients who get the most out of it are the ones who treat it as part of a broader healthspan strategy rather than a magic bullet.

Animal Data vs. Human Data

It is worth being explicit about the gap between animal and human evidence, because much of what gets repeated on longevity podcasts comes from rodent studies. In mice, NAD+ precursors have been shown to improve a range of age-related markers — running endurance, mitochondrial function, vascular health, cognitive performance — and in some genetic contexts to extend lifespan. Mice are not small humans. Their physiology is similar enough to make findings worth pursuing in people, and different enough that translation is never guaranteed.

Where human trials exist, the most consistent findings have been:

• Oral NR and NMN reliably increase blood NAD+ markers
• Effects on muscle NAD+ are real but smaller than blood NAD+ effects
• Improvements in insulin sensitivity have been seen in some populations, especially prediabetic adults
• Modest changes in body composition and physical performance markers
• Generally good tolerability and safety

What we have not yet seen in published human trials is a clean lifespan-extension result, a clear effect on hard cardiovascular endpoints, or a definitive cognitive outcome. Those are harder studies to run — they take years and large numbers of participants — and they are slowly accumulating. The picture in 2026 is that the foundational biology is solid, the human trials so far are encouraging without being conclusive, and the clinical practice that has built up around NAD+ has grown faster than the formal evidence base. That is not unusual in medicine, but it is worth knowing.

Use Cases and Outcomes by Goal

Different patients come to NAD+ for different reasons. Here is how to think about fit by goal.

Energy and Fatigue Resolution

The single most common reason patients pursue NAD+ is unexplained or persistent fatigue. We always start with labs (thyroid, ferritin, B12, full metabolic panel, hormone panel where appropriate, and inflammatory markers) before assuming NAD+ is the answer — fatigue has many causes and many of them are easier to fix. But for patients whose labs are reasonable and who still feel like they are running on empty, NAD+ work is one of the most reliably effective interventions we have, particularly when combined with addressing sleep and metabolic health.

Cognitive Performance and Clarity

Patients in cognitively demanding work — physicians, attorneys, executives, founders — often report meaningful improvements in mental endurance, focus, and clarity from a structured NAD+ protocol. Whether the changes show up on cognitive testing in a research setting is a separate question; what we observe clinically is consistent enough that we treat it as a real effect for many patients.

Athletic Recovery and Performance

NAD+ supports the metabolic machinery underlying recovery — mitochondrial function, ATP production, oxidative damage repair. Athletes and active patients frequently report faster recovery between sessions, less perceived soreness, and improved tolerance for higher training loads. We typically combine NAD+ work with structured lab monitoring to make sure inflammation, hormones, and recovery markers are all moving in the right direction together.

Post-Illness Recovery (Long COVID and Post-Viral Fatigue)

The post-2020 era has produced a generation of patients with persistent post-viral fatigue, autonomic dysregulation, and cognitive complaints. NAD+ has emerged as one of the more useful tools in supporting this population, alongside other measures. The biological logic is clean — viral illnesses chew through NAD+ via PARP activation and oxidative stress, and the post-illness state often looks like a depleted NAD+ pool that has not recovered. Replenishing it does not "cure" long COVID, but in our experience it frequently helps patients feel meaningfully better while their broader recovery continues.

Healthy Aging and Preventive Longevity

For patients in their 30s, 40s, and 50s who are not symptomatic but want to invest in long-term healthspan, NAD+ becomes one component of a broader plan. We approach this with humility: there is no proof that any specific NAD+ regimen extends human lifespan. There is plausible biology and consistent patient reports of feeling and functioning better. For people who care about how they age and are willing to invest in evidence-informed but not yet proven longevity work, it is a reasonable choice.

Addiction Recovery Support

NAD+ has a long-running role in addiction recovery practice, particularly for opioid and alcohol withdrawal. The mechanism is not fully understood but is thought to involve restoration of NAD+ pools depleted by chronic substance use. We frame this clearly as complementary — NAD+ is not a replacement for evidence-based addiction treatment, including counseling, peer support, and (where appropriate) medications. It is a piece of a recovery plan, not the entire plan.

Alongside Hormone Optimization

Many patients on testosterone replacement therapy or hormone replacement therapy find that adding NAD+ support to a hormone protocol yields better results than either alone. The mechanism makes sense: hormones drive metabolic activity, metabolic activity demands NAD+, and depleted NAD+ pools cap the ceiling on how much benefit hormone optimization can produce. This integration is one of the patterns we see most often in our longevity-focused practice.

Lifestyle Pillars That Support Endogenous NAD+

The point we keep returning to: NAD+ therapy works best when the lifestyle around it is also supporting NAD+. Here are the pillars.

Sleep

Aim for seven to nine hours of consistent, high-quality sleep. Anchor your wake time. Get morning light. Avoid late caffeine and late alcohol. Sleep is when much of NAD+-dependent repair happens.

Exercise

Mix endurance work and resistance training. Both stress mitochondria in ways that drive adaptation and NAD+ utilization. Even modest, consistent movement matters more than occasional heroic sessions.

Eating Windows

Avoid constant grazing. A reasonable eating window — say, 10 to 12 hours — gives metabolic flexibility and supports the NAD+/NADH ratio. You do not need extreme fasting; you need not snacking around the clock.

Diet Quality

Whole foods, adequate protein, plenty of vegetables, sufficient micronutrients (especially the B vitamins that support NAD+ synthesis). This is not a fad-diet conversation. It is the same advice nutrition science has converged on for decades.

Stress Management

Chronic stress drives chronic inflammation drives CD38 expression drives NAD+ depletion. Managing stress — through whatever means works for you — is not optional. It is biochemistry.

Alcohol

Alcohol is metabolized through pathways that consume NAD+ aggressively. Heavy drinking is one of the most efficient ways to deplete NAD+ short of severe illness. Moderation matters.

Smoking and Vaping

Both drive oxidative stress and inflammation. Both deplete NAD+ pools. Both undermine longevity work in ways that no IV protocol can compensate for.

Patients who tighten up these pillars while pursuing NAD+ therapy almost always do better than patients who try to use NAD+ as a workaround for lifestyle they do not want to change. The therapy is a multiplier on the foundation; it is not a substitute for it.

Safety, Contraindications, and Monitoring

NAD+ has a strong safety profile in supervised clinical use. That said, it is not for everyone, and there are real considerations.

What to Expect During Administration

IV NAD+ can cause a transient feeling of pressure in the chest, flushing, or mild nausea if infused too quickly. The remedy is simple: slow the drip. Most patients tolerate it well at the right rate. IM injections can cause local discomfort and mild flushing. Sublingual and oral forms are generally uneventful.

Common Contraindications and Cautions

• Pregnancy and breastfeeding: NAD+ therapy is not appropriate. There is not enough safety data.
• Active cancer: Requires careful evaluation. Some research raises questions about how NAD+ availability interacts with tumor metabolism. This is a discussion to have with a provider who knows your full picture.
• Significant cardiovascular disease: Requires medical clearance before IV protocols.
• Severe liver or kidney disease: Requires individualized evaluation.
• Bleeding disorders: IV access requires standard precautions.

Monitoring

Good NAD+ practice always includes baseline labs and periodic re-checks. Standard monitoring usually covers metabolic panels, inflammatory markers, hormone status where relevant, and symptom tracking. We also use body composition data over time to see how interventions are translating into measurable changes. NAD+ blood-level testing exists but its clinical utility is still emerging — we use it selectively rather than reflexively.

Anyone offering NAD+ without this kind of clinical scaffolding is selling a product, not a protocol. The safety and effectiveness of NAD+ work depend heavily on the surrounding evaluation.

The Impact Health Approach

Here is how we structure NAD+ care for patients across our Mississippi locations.

Step One: Labs First

Before anyone starts NAD+, we run a thorough lab panel. Thyroid, comprehensive metabolic, B12, ferritin, fasting insulin, hemoglobin A1c, hormone panel where appropriate, lipid panel, inflammatory markers. The reason is simple: many of the symptoms patients hope NAD+ will resolve are caused by easily treatable issues that show up on labs. We want to address those first or in parallel, not bury them under therapy.

Step Two: Body Composition Baseline

For patients with metabolic or longevity goals, we do 3D body composition analysis at baseline and periodically thereafter. This gives us objective data on lean mass, fat distribution, and changes over time — which matters because subjective reports about how someone is feeling are useful but not enough on their own.

Step Three: Provider-Supervised Protocol

NAD+ is administered by trained clinical staff under provider supervision. We design the protocol — IV, IM, oral, or a combination — based on goals, labs, and tolerance. We adjust over time based on response. This is not a "show up and get a bag" experience; it is part of a clinical relationship.

Step Four: Integration With Other Therapies

Where it makes sense, we integrate NAD+ work with testosterone replacement therapy, hormone replacement therapy for women, peptide therapy, glutathione support, Lipo and B12 for metabolic support, and food allergy testing when chronic inflammation is a concern. The point is that NAD+ rarely stands alone in a longevity plan. It works best as one piece of a coherent strategy.

Step Five: Lifestyle and Recovery Coaching

Because NAD+ is downstream of so many lifestyle factors, we spend real time on the lifestyle conversation. Sleep architecture, training program structure, eating windows, stress patterns, alcohol use, screen and light exposure — all of it shapes how much benefit a patient extracts from a given protocol. We would rather adjust two pieces of a patient's daily life than chase symptoms with a more aggressive infusion schedule. The lifestyle work is also what determines whether the gains from a clinical NAD+ protocol stick once the loading phase is done.

Step Six: Follow-Up and Iteration

We bring patients back at structured intervals to repeat labs, repeat body composition, review symptom changes, and adjust the plan. Longevity care is iterative. The protocol that worked at year one may not be the right protocol at year three, and that is fine — it is supposed to evolve with the data.

Where We Practice

NAD+ therapy and the surrounding longevity protocols are available at all three Impact Health locations:

• Oxford, MS — convenient for the university community and surrounding region
• Olive Branch, MS — serving the DeSoto County and greater Memphis area
• Corinth, MS — serving northeast Mississippi

See all locations for hours and contact information, or call 877-665-6767 to talk through whether NAD+ is a fit.

Cost Philosophy

NAD+ therapy is cash-pay. Most insurance does not cover it because it does not meet the strict criteria insurers use for "medically necessary" treatment of a specific diagnosis. We have made peace with this and so have our patients.

What we will not do is publish prices in this article. Prices change, protocols vary, and quoting a number out of context tends to mislead more than it informs. What we will say is that the cost of a serious NAD+ protocol is meaningful — comparable to a meaningful gym membership, premium fitness coaching, or any other invested wellness practice — and that we work with patients to design protocols that fit both their goals and their budgets. We would rather have a patient on a sustainable maintenance plan than a six-week sprint they cannot continue.

For specific pricing, call 877-665-6767 or visit our contact page. The how it works page also walks through what to expect.

Frequently Asked Questions

Does NAD+ therapy actually slow aging?

The honest answer: NAD+ therapy supports many of the cellular processes that are involved in aging well. It has not been proven to extend human lifespan. Patients consistently report feeling and functioning better, and there is plausible biology behind that. We frame it as healthspan support, not life extension.

Can young people benefit from NAD+ therapy?

Yes, but with realistic expectations. Younger patients with high baseline NAD+ usually notice less dramatic changes than patients in their 50s and 60s. Where younger patients tend to benefit most is in recovery from intense training, support during high-demand work periods, and recovery from illness. It is not a daily must-have at age 30; it is a tool to be used selectively.

Will I feel different right away?

Some patients feel a difference during or shortly after their first IV — usually a clearer head, more energy, sometimes better sleep that night. Others need a series of sessions before they notice. The patients who report the most dramatic shifts tend to be those who started from a more depleted state.

What if I have a heart condition?

It depends on the condition. Stable, well-managed conditions are usually fine with provider clearance and slower infusion rates. Acute or unstable conditions are not an appropriate time for elective IV therapy. We will ask about your history and make a recommendation.

Can I drive after an IV?

Most patients can. Some feel slightly tired immediately after, and a few feel energized. We recommend bringing something to read or work on during the infusion and being honest about how you feel before driving home.

NMN vs. NR vs. IV — which is best?

Different tools for different jobs. IV NAD+ produces the most pronounced clinical effects but is the most time and resource intensive. NMN and NR are convenient daily oral options that reliably raise NAD+ markers but tend to produce more subtle clinical effects. For symptomatic patients, we usually recommend starting with IV or IM and using oral precursors for maintenance. For preventive use in healthy patients, oral precursors plus periodic IM or quarterly IV may be enough.

Do I really need labs first?

Yes. Skipping labs is how patients end up paying for NAD+ to "treat" fatigue that turns out to be untreated thyroid disease, low ferritin, or sleep apnea. Labs save you money and time and produce a better outcome.

Can I do NAD+ with TRT or HRT?

Yes, and the combination is one of the more common patterns in our practice. Hormones drive metabolic demand; NAD+ supports the metabolic machinery that meets that demand. Done together they often work better than either alone.

Can pregnant women do NAD+ therapy?

No. Pregnancy and breastfeeding are not appropriate for elective NAD+ therapy. There is not enough safety data, and the principle is to avoid unnecessary interventions during these life stages.

What about a history of cancer?

This requires individualized evaluation. Some research has raised questions about how NAD+ availability interacts with tumor metabolism. The answer is not a blanket no, but it is also not a blanket yes — we will want to know your full history and ideally coordinate with your oncology team.

Will my insurance cover this?

Almost certainly not. NAD+ therapy is overwhelmingly cash-pay in the United States. We will give you straight answers about cost and help you build a plan that is sustainable.

How will I know it's working?

A combination of subjective and objective markers. Subjective: how you feel, how you sleep, how you recover, how you focus. Objective: lab changes over time, body composition trends, performance markers, and where applicable, biomarkers of inflammation and metabolic health. We track these together because subjective and objective improvements often correlate but sometimes do not, and both matter.

The Decade Ahead in NAD+ Research

It is worth ending with a brief look at where the field is heading. Several lines of research stand out as likely to shape clinical practice over the next several years.

CD38 inhibition. If CD38 is one of the major drivers of age-related NAD+ loss, then selective CD38 inhibitors could preserve NAD+ pools without the need for ongoing supplementation. Early-stage compounds are in research pipelines, and natural CD38-inhibiting compounds (apigenin, quercetin and related flavonoids) are already part of some longevity stacks, although the human evidence on the natural compounds is preliminary.

Sirtuin activators. Direct activators of sirtuins, particularly SIRT1, have been pursued for years. Resveratrol was the original member of this class; its successors are still being developed. The intersection of sirtuin activation and NAD+ availability is an obvious place to look.

NAD+ measurement. Reliable, accessible blood and tissue NAD+ measurement would let clinicians actually titrate protocols against a number rather than against symptoms alone. The technology is improving and the cost is falling. Within a few years, NAD+ measurement may be a routine part of longevity care.

Combination protocols. The most likely future of clinical NAD+ practice is multi-pronged: precursor supplementation plus periodic clinical replenishment plus CD38 modulation plus sirtuin support, all wrapped around aggressive lifestyle work. The patients getting the best outcomes already are doing something close to this informally; the field is gradually formalizing it.

None of this is a reason to wait to start. The tools we have today are useful tools, and starting earlier almost always produces better results than starting later. But it is reasonable to expect the toolkit to keep improving.

Closing Thoughts and Next Steps

NAD+ is one of the more genuinely interesting molecules in human biology. The research case for its role in aging is strong. The clinical case for thoughtful supplementation is reasonable. The hype case — the one that sells "anti-aging miracles" online — overshoots what the science supports.

If you want to use NAD+ as a real tool, treat it as one piece of a bigger picture. Get your labs done. Get your sleep, training, and nutrition in order. Work with a clinical team that does the evaluation, designs a real protocol, and follows up with data. Treat the IV chair as part of a relationship, not a one-night stand.

Done that way, NAD+ becomes one of the more useful interventions we have for helping people feel better, recover better, and age more gracefully into their later decades. It is not magic. It is biochemistry, used well.

If you are ready to talk through whether NAD+ therapy is a fit for your situation, we would love to help. Call 877-665-6767, book a consultation, or visit our NAD+ services page for more detail. You can also explore our location pages for Oxford, Olive Branch, and Corinth to find the practice closest to you.

Want to read more before reaching out? Browse the rest of our blog for deep dives on related topics, or jump straight to scheduling a consult when you're ready.

Medical Disclaimer

This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. NAD+ therapy and related interventions described here should only be undertaken under the supervision of a qualified healthcare provider after an appropriate evaluation. Individual responses vary. Statements in this article have not been evaluated by the FDA. NAD+ therapy is not intended to diagnose, treat, cure, or prevent any disease. Discuss your specific medical history, medications, and goals with a licensed provider before starting any new therapy. If you have an active medical condition or take prescription medications, do not start NAD+ therapy without first consulting your physician.